Consistent with these findings, liver FMO3 knockdown also reduced liver and plasma lipid levels, the bile acid pool size, and glucose and insulin levels and prevented atherosclerosis in LDL receptor-deficient mice [65], suggesting multiple mechanistic processes involved in TMAO/FMO3-mediated foam cell formation in vivo. The gene discussed is FMO3; the disease is atherosclerosis.